A class action lawsuit against Cynosure, Inc., manufacturer of the MonaLisa Touch laser device for vaginal rejuvenation, alleges its defective design causes adverse effects like pain, dryness, and infections. Cynosure denies the claims, touting the device’s safety and popularity.
| Complete Date | Case | Citation | Court | Short Summary |
|---|---|---|---|---|
| August 2021 | Johnson et al. v. Cynosure, Inc. | 3:21-cv-00957 (D. Del.) | U.S. District Court for the District of Delaware | Class action lawsuit filed alleging the MonaLisa Touch causes vaginal pain, burning, dryness, bleeding, discharge, painful sex, UTIs, stenosis, and atrophy. Cynosure denies these claims. |
| Ongoing | Discovery and Motions Phase | N/A | N/A | Both parties engaged in discovery process, gathering evidence and witness testimonies. Motions to dismiss or certify the class are expected. |
| 2019 | FDA Approval | N/A | N/A | MonaLisa Touch receives FDA clearance for marketing as a treatment for vaginal dryness and other vulvovaginal atrophy (VVA) symptoms. |
| 100,000+ Users | Global Application | N/A | N/A | Cynosure reports the device has been used by over 100,000 women worldwide, emphasizing its popularity. |
Details and Latest Developments:
- The lawsuit highlights potential risks associated with the MonaLisa Touch, raising concerns beyond reported benefits.
- Limited long-term data on the device’s safety and efficacy further fuels the debate surrounding its use.
- The ongoing lawsuit is in the discovery and motions phase, with both parties gathering evidence and potentially seeking dismissal or class certification.
Important Note: This information is not a substitute for medical advice. Consult your doctor to discuss the potential risks and benefits of the MonaLisa Touch before considering treatment.
